-
Mashup Score: 4
Gilead’s CEO says he’s committed to making sure people around the world can get his firm’s new HIV prevention shot Yeztugo.
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 2Cogent Biosciences-Blueprint Medicines tiff turns spicy on eve of immune drug study readout - 2 hour(s) ago
A rivalry between two drugmakers, Cogent Biosciences and Blueprint Medicines, has turned ugly.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Cogent Biosciences-Blueprint Medicines tiff turns spicy on eve of immune drug study readout https://t.co/dNW2eCvq8D
-
-
Mashup Score: 7Top gene therapy regulator forced out at FDA - 3 hour(s) ago
Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her deputy Rachael Anatol have been
Source: www.statnews.comCategories: General Medicine NewsTweet-
Top gene therapy regulator forced out at FDA. https://t.co/c8qiP4eqao
-
-
Mashup Score: 1U.K. decision blocks a pair of Alzheimer’s drugs from access through its national health service - 3 hour(s) ago
A U.K. health agency said the Alzheimer’s drugs Kisunla and Leqembi are not cost-effective, meaning they won’t be offered through the NHS.
Source: www.statnews.comCategories: General Medicine NewsTweet-
A U.K. health agency reiterated that the limited benefits of a pair of new Alzheimer’s drugs do not justify their high prices, meaning the medicines won’t be made available through the National Health Service. https://t.co/vcjt2zrVwI
-
-
Mashup Score: 3
New brain-computer interface reduced time lag in translating thoughts into speech in a meaningful advance for the field.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Reliable communication for people with paralysis is nearing reality. Researchers have now demonstrated that a brain-computer interface can reliably translate thoughts into speech, including matching a person’s intended tone and pitch. https://t.co/EXUJ8QP1My
-
-
Mashup Score: 6
Gilead’s CEO says he’s committed to making sure people around the world can get his firm’s new HIV prevention shot Yeztugo.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Gilead’s CEO on the approval of a powerful new drug to prevent HIV Daniel O’Day says he’s committed to making sure that people around the world can get his company’s new injection https://t.co/iDXvJbkecy
-
-
Mashup Score: 1
Why did the Food and Drug Administration suddenly oust one of its top gene therapy regulators?
Source: www.statnews.comCategories: General Medicine NewsTweet-
Why did the Food and Drug Administration suddenly oust one of its top gene therapy regulators? https://t.co/CASgCEaP8N
-
-
Mashup Score: 6
Two advocates demand systemic change in addiction treatment that prioritizes safety and accountability above all else.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Two advocates demand systemic change in addiction treatment that prioritizes safety and accountability above all else. https://t.co/3K8U78gUCK
-
-
Mashup Score: 13Gilead’s CEO on the approval of a powerful new drug to prevent HIV - 11 hour(s) ago
Gilead’s CEO says he’s committed to making sure people around the world can get his firm’s new HIV prevention shot Yeztugo.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Gilead’s CEO on the approval of a powerful new drug to prevent HIV Daniel O’Day says he’s committed to making sure that people around the world can get his company’s new injection https://t.co/iDXvJbkecy
-
-
Mashup Score: 9Cogent Biosciences-Blueprint Medicines tiff turns spicy on eve of immune drug study readout - 12 hour(s) ago
A rivalry between two drugmakers, Cogent Biosciences and Blueprint Medicines, has turned ugly.
Source: www.statnews.comCategories: General Medicine NewsTweet-
A rivalry between two drugmakers, Cogent Biosciences and Blueprint Medicines, has turned ugly. https://t.co/fiFQAKETJc
-
Gilead’s CEO on the approval of a powerful new drug to prevent HIV https://t.co/SturiBXHXL